Skipping extra radiation for breast cancer after chemo
Part of Cancer, Skin clinical trials.
This study tests whether some breast cancer patients with advanced lymph node involvement (N3) can safely skip extra radiation to those nodes after chemotherapy and surgery. The goal is to reduce side effects while maintaining effective treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have been diagnosed with breast cancer that has spread to lymph nodes above the collarbone, under the breastbone, or deep in the armpit (called N3).
- The cancer has not spread to other parts of the body (no distant metastasis).
- You have already completed chemotherapy before surgery, and if your cancer is HER2-positive or triple-negative, you received appropriate targeted or immune therapy.
- You had breast surgery (lumpectomy or mastectomy) and removal of armpit lymph nodes, and imaging shows no remaining cancer in the originally affected lymph nodes.
- You have not had radiation therapy to the breast or chest before, and you are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests giving a focused, higher dose of radiation to the lymph nodes above the collarbone after breast cancer treatment. It is for patients whose cancer did not fully disappear from those nodes after pre-surgery chemotherapy, to see if extra radiation can help prevent recurrence.
This trial compares two ways of giving radiation to lymph node areas near the collarbone after surgery for invasive breast cancer. It aims to see which radiation approach works better and is safer for preventing cancer returning in these lymph nodes.
This study compares two radiation schedules for breast cancer patients at high risk of cancer returning in lymph nodes. Both use modern radiation therapy, but one delivers treatment faster (ultra-hypofractionated) while the other uses a more moderate schedule. The goal is to see which approach works better with fewer side effects.
This trial tests whether some women with low-risk breast cancer that has spread to a few lymph nodes can safely skip radiation therapy after surgery. It aims to reduce side effects while keeping the cancer from coming back.
This trial tests whether women who have a complete response to chemotherapy before breast-conserving surgery can safely skip a special radiation boost to the tumor bed. It aims to reduce unnecessary treatment side effects while maintaining good outcomes.
This trial is for women 50 and older with early-stage, hormone-positive or HER2-positive breast cancer. It tests whether it is safe to skip radiation therapy after a lumpectomy if an MRI before surgery shows the breast tissue looks a certain way.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.